Antenatal immunization: Concepts and challenges

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 7, 2014, Pages 2118-2122

  Jones, Chrissie ^a   Heath, Paul ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antenatal; Immunisation; Infant; Infectious disease; Maternal; Pregnancy; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; PERTUSSIS VACCINE; STREPTOCOCCUS VACCINE;

ANTENATAL IMMUNIZATION; ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FETUS DEATH; GROUP B STREPTOCOCCAL INFECTION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION RISK; INFLUENZA; PASSIVE IMMUNIZATION; PERTUSSIS; PREGNANCY; REVIEW; STILLBIRTH; TERATOGENICITY; TETANUS; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; FEMALE; NEWBORN; PRENATAL CARE; PROCEDURES;

FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; INFANT, NEWBORN; PREGNANCY; PRENATAL CARE;

EID: 84908439538     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.29610     Document Type: Review

References (17)

1. Courtesy of G.Amirthalingam, 2013 Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill. 2013;18(38). pii: 20587. a. CMO Annual Report 2011. Accessed at https://www.gov.uk/government/publications/cmo-annual-report-2011-volume-one-on-the-state-of-the-public-s-health
2. Englund JA, Anderson EL, Reed GF, Decker MD, Edwards KM, Pichichero ME, Steinhoff MC, Rennels MB, Deforest A, Meade BD. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96:580-4; PMID:7659480
3. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, O'Connell LA, Cafferkey M, Verlander NQ, Nicoll A, et al.; PHLS Group B Streptococcus Working Group. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363:292-4; PMID:14751704; http://dx.doi.org/10.1016/S0140-6736(03)15389-5
4. Jones C, Pollock L, Barnett SM, Battersby A, Kampmann B. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. Vaccine 2014; 32:996-1002; PMID:24342250; http://dx.doi.org/10.1016/j.vaccine.2013.11.104
5. McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD. Attitudes towards vaccination against group B streptococcus in pregnancy. Arch Dis Child 2013; (Forthcoming); PMID:24356806
6. Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet Gynecol 2012; 207(Suppl):S33-7; PMID:22920057; http://dx.doi.org/10.1016/j.ajog.2012.06.072
7. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-31; PMID:10648763; http://dx.doi.org/10.1056/NEJM200001273420401
8. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012:985646; PMID:22235228; http://dx.doi.org/10.1155/2012/985646
9. Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, Hviid A. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ 2012; 344:e2794; PMID:22551713; http://dx.doi.org/10.1136/bmj.e2794
10. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, et al.; Active Bacterial Core surveillance/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299:2056-65; PMID:18460666; http://dx.doi.org/10.1001/jama.299.17.2056
11. Sanchez-Schmitz G, Levy O. Development of newborn and infant vaccines. Sci Transl Med 2011; 3:90ps27; PMID:21734174; http://dx.doi.org/10.1126/scitranslmed.3001880
12. Schofield FD, Tucker VM, Westbrook GR. Neonatal tetanus in New Guinea. Effect of active immunization in pregnancy. Br Med J 1961; 2:785-9; PMID:13748431; http://dx.doi.org/10.1136/bmj.2.5255.785
13. Sheffield JS, Munoz FM, Beigi RH, Rasmussen SA, Edwards KM, Read JS, Heine RP, Ault KA, Swamy GK, Jevaji I, et al. Research on vaccines during pregnancy: reference values for vital signs and laboratory assessments. Vaccine 2013; 31:4264-73; PMID:23906887; http://dx.doi.org/10.1016/j.vaccine.2013.07.031
14. Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 2009; 201:547-52; PMID:19850275; http://dx.doi.org/10.1016/j.ajog.2009.09.034
15. van den Berg JP, Westerbeek EA, Berbers GA, van Gageldonk PG, van der Klis FR, van Elburg RM. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 2010; 29:801-5; PMID:20803841; http://dx.doi.org/10.1097/INF.0b013e3181dc4f77
16. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-64; PMID:18799552; http://dx.doi.org/10.1056/NEJMoa0708630
17. Zheteyeva YA, Moro PL, Tepper NK, Rasmussen SA, Barash FE, Revzina NV, Kissin D, Lewis PW, Yue X, Haber P, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012; 207:e1-7; PMID:22727350